ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$13.74
Tradestie Score
37
Market Cap
$1.78B
Revenue Growth
-0.8%
Analyst Upside
+21.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$322.28
|
$5.20B | 40.8 | 63 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$56.48
|
$4.94B | - | 57 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.46
|
$4.93B | - | 54 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$64.19
|
$4.84B | - | 67 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$140.06
|
$3.98B | 135.1 | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$107.39
|
$3.91B | - | 55 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.33
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.37
|
$3.68B | - | 60 | Compare |
More ABCL Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry